Highlights AstraZeneca Pharma India Limited

Equities

ASTRAZEN

INE203A01020

Delayed Bombay S.E. Other stock markets 12:22:04 2024-05-09 am EDT			5-day change	1st Jan Change
5,267 ^INR	-0.83%		-1.25%	-4.58%

Apr. 08	AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	CI
Mar. 25	AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	Mar. 11	MT
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	Mar. 11	CI
AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 08	CI
AstraZeneca Gets Indian Drug Regulator's Nod to Import Andexanet Alfa Powder for Solution for Infusion	Jan. 21	MT
Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024	Dec. 21	MT
AstraZeneca Pharma India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
AstraZeneca Gets Indian Drug Regulator's Nod to Import Pharmaceutical Formulations for Palivizumab	23-10-02	MT
Astrazeneca Pharma India Limited Receives Permission to Import Pharmaceutical Formulations Of New Drug For Sale Or For Distribution In Form CT-20 From Central Drugs Standard Control Organisation For Palivizumab	23-09-30	CI
AstraZeneca Pharma India Limited Approves Dividend for the Financial Year 2022-2023	23-08-17	CI
AstraZeneca Pharma India Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
AstraZeneca Pharma Launches Neurofibromatosis Type 1 Drug in India	23-08-10	MT
AstraZeneca Pharma India Limited Announces Launch of Selumetinib 10 Mg and 25 Mg Capsule	23-08-09	CI
AstraZeneca Pharma India Limited Proposes to Declare Dividend for the Financial Year 2022-23	23-07-22	CI
Ex-dividend day for final dividend	23-07-13	FA
AstraZeneca Gets Regulatory Nod to Import Tremelimumab (Imjudo) Concentrate	23-06-01	MT
AstraZeneca Pharma India Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
AstraZeneca Pharma India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-30	CI
AstraZeneca Pharma India Limited Recommends Dividend for the Financial Year 2022-23	23-05-30	CI
AstraZeneca Pharma India Limited Receives Permission in Form CT-20 to Import for Sale and Distribution of Trastuzumab Deruxtecan	23-05-03	CI
Astrazeneca Pharma India Limited Receives No Objection for an Additional/Expanded Indication from the Central Drugs Standard Control Organization	23-02-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AstraZeneca Pharma India Limited

Equities

ASTRAZEN

INE203A01020

Highlights

Filters